1 results found

Maria Francesca Testa, Mirko Pinotti, Alessio Branchini, Maria Elisa Mancuso, Francesco Bernardi, Dario Balestra

Background: Among F8 mutation types, main determinants of inhibitor development after replacement therapy in Hemophilia A, nonsense mutations display wide variation in the associated risk. Molecular m...

Molecular Medicine 2026-04-23 rs-9414495
F8 PTCs Hemophilia A translational readthrough inhibitory antibody peptide MHCII affinity personalized medicine
Back to Top
Home
Browse
Submit
About
0.069923s